Overall, even if historically RHOA was described as a molecule with pro-oncogenic functions because it is frequently overexpressed in human tumors and associated with tumor progression, recent findings on RHOA mutations describe a more complex and heterogeneous landscape, at least in human lymphoma. This evidence concerns the gene RHOA and neoplasm.